Multiple Sclerosis Treatment Market Global Growth, Demand, Top players, Industry Size, Share, Upcoming Trends, Analysis and By Forecast 2030

Market Research Future Insights

The global Multiple Sclerosis Treatment Market size is evaluated at USD 23.68 billion in 2021. The market is forecast to grow from USD 25.43 billion in 2022 to USD 28.09 billion by 2030, exhibiting a CAGR of 2.80% during the forecast period.

Multiple sclerosis (MS) is a chronic inflammatory immune- mediated disease that affects nerve cells in the spinal cord and brain, causing demyelination, axonal transection, and neurodegeneration. Injectable, oral and infused medications, muscle relaxants, antidepressants, and physical therapy are some of the most extensively used therapies. Interferon- beta and glatiramer acetate are injectable therapies that are given under the skin or into the muscle; oral medications include teriflunomide, dimethyl fumarate, and cladribine; and intravenous infusion treatments include ocrelizumab, alemtuzumab and natalizumab.

Get FREE Sample copy of Report @ https://www.marketresearchfuture.com/sample_request/940

Market Segmentation

On the basis of type, the market is classified into immune suppressants and immune modulators. The immune suppressants segment was the highest contributor to the market, owing to their beneficial effects for patients suffering from relapsing- remitting multiple sclerosis (RRMS) by weakening the immune system, thereby suppressing the autoimmune attack in the patient’s body and preventing relapses. In extension, the increase in product approvals for the treatment of MS therapies is expected to propel the market growth universally. Presently, the immune suppressants that have been approved for use only in relapsing forms of MS include alemtuzumab, dimethyl fumarate, fingolimod, glatiramer acetate, interferon beta preparations, natalizumab, ocrelizumab, and teriflunomide.

On the basis of route of administration

Depending on the route of administration, the market is bifurcated into oral, injectable, and intravenous. The oral route of administration promotes patient satisfaction and increases therapeutic compliance. Significant therapeutic advances in the new orally administered drugs approved for the MS treatment represent a lift to the growth of the market. Three oral drugs have been approved by regulatory agencies for the treatment of MS, which include fingolimod, teriflunomide and dimethyl fumarate. The mechanisms of action, efficacy, and safety of these medicines that have yielded admiring results in phase III trials, which is a key factor that contributes toward the growth of the global market.

Regional Analysis

The market size in North America lay at USD11.36 billion in 2021. Primary factors liable for the region’s dominant share in the multiple sclerosis medicines market include increasing R&D investment, new product launches, and rising demand for immunosuppressant and molecular antibody drugs.

Europe is estimated to be the second-most prominent region in terms of revenue in 2021, owing to the active government recommendations and favorable health reimbursement programs. also, the increasing prevalence of the condition across the region is anticipated to further surge the multiple sclerosis medicines demand, thereby adding the market growth.

The market in Asia Pacific is likely to register the highest CAGR during the cast period. This significant growth rate is attributable to improved distribution networks of pharmaceutical companies in arising economies. also, growing government action in numerous countries to reduce the cost of treatment pertaining to MS is another significant factor boosting the demand for MS drugs across the region.

The market is projected to develop in the Middle East & Africa and Latin America due to the rising prevalence of neurological diseases and improving healthcare spending

Key Players

Pfizer,Merck and Co,Teva Pharmaceutical,Sanofi,Bayer,Biogen,Roche,Novartis,CinnaGen,Mylan,Bristol- Myers Squibb,Janssen Pharmaceuticals,Acorda Therapeutics

Browse Full Report Details @  https://www.marketresearchfuture.com/reports/multiple-sclerosis-treatment-market-940

More Related Report

Continuous Positive Airway Pressure Devices Market Research Report – Global Forecast till 2030

Blood Coagulation Testing Market Research Report – Global Forecast till 2030

Hospital Furniture Market Research Report – Global Forecast till 2030

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Tags: Multiple Sclerosis Treatment Market Forecast, Multiple Sclerosis Treatment Market analysis, Multiple Sclerosis Treatment Market growth, Multiple Sclerosis Treatment Market share, Multiple Sclerosis Treatment Market trends, Multiple Sclerosis Treatment Market Demand, Multiple Sclerosis Treatment Market Size, Multiple Sclerosis Treatment Market See Campaign: https://www.marketresearchfuture.com/reports/multiple-sclerosis-treatment-market-940

Contact Information:

Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America

Tags:
Wire, Research Newswire, English